Alnylam Pharmaceuticals
ALNY
#618
Rank
โ‚น2.779 T
Marketcap
โ‚น21,473
Share price
3.69%
Change (1 day)
79.37%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) Fails to deliver data

Key failure to deliver metrics for Alnylam Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alnylam Pharmaceuticals (ALNY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alnylam Pharmaceuticals (ALNY) - since 2013

Volume in USD (price x number of shares), data since 2013

Alnylam Pharmaceuticals (ALNY) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚น9.85 M-77.19%
2024โ‚น43.18 M-16.96%
2023โ‚น51.99 M-66.55%
2022โ‚น0.15 B200.46%
2021โ‚น51.74 M-9.83%
2020โ‚น57.38 M52.34%
2019โ‚น37.66 M46.52%
2018โ‚น25.7 M-70.97%
2017โ‚น88.54 M191.96%
2016โ‚น30.32 M-14.94%
2015โ‚น35.65 M68.07%
2014โ‚น21.21 M152.1%
2013โ‚น8.41 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚น3.01 Mโ‚น8.57 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น23.26 Mโ‚น51.47 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.8 Mโ‚น36.33 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.41 Mโ‚น29.64 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.09 Mโ‚น5.43 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น44.97 Mโ‚น0.15 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น6.82 Mโ‚น53.35 M๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น12.18 Mโ‚น42.24 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel